Company profile: Collagen Solutions
1.1 - Company Overview
Company description
- Provider of medical-grade collagen formulations and components for regenerative medicine, medical devices, and in-vitro diagnostics, offering custom collagen engineering, GMP contract manufacturing, and product development. Expertise includes native, soluble, fibrillar, powdered and freeze-dried collagen, tissue-engineered materials (pericardium, bone, tendons), and regulatory compliance to GMP, EDQM, ISO13485, ISO 22442.
Products and services
- Contract Collagen Manufacturing: Runs a GMP-compliant facility to fabricate engineered collagen components, meeting EDQM, ISO13485, and ISO 22442 standards for quality-controlled production to global medical device companies
- Collagen Formulations: Produces medical-grade collagen in soluble, fibrillar, freeze-dried, native, and powdered forms for regenerative medicine, medical devices, and in‑vitro diagnostics applications
- Collagen-Based Medical Device Product Development: Architects custom-engineered biomaterial assemblies, supporting medical device companies to develop new or improved devices with engineered collagen components or finished products
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Collagen Solutions
IGS GeboJagema
HQ: The Netherlands
Website
- Description: Provider of mold design, manufacturing, qualification, and maintenance services and precision components for medical devices such as asthma inhalers, insulin pens, and blood diagnostic devices.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full IGS GeboJagema company profile →
Prism Pharma
HQ: United States
Website
- Description: Provider of cardiovascular injectable products for acute care, developing and commercializing therapies in the United States, including NEXTERONE, an antiarrhythmic injectable amiodarone, and PM103, an intravenous clopidogrel bisulfate.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Prism Pharma company profile →
ViaCord
HQ: United States
Website
- Description: Provider of women's health biotechnology services, including ViaCord for preserving newborn umbilical cord blood, cord tissue banking, and ViaCyte for cryopreservation of unfertilized eggs, plus newborn genomic offerings such as DNA preservation, celiac and lactose risk testing, a panel analyzing over 270 genes, and whole genome sequencing of 22,000 genes.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ViaCord company profile →
Graniten
HQ: Sweden
Website
- Description: Provider of machine solutions for pharmaceutical manufacturing and healthcare automation, offering the Graniten Flexline modular packaging platform for high-mix, low-volume formats with near-zero changeover, TS230 case packer/palletizer, customized packaging and healthcare automation solutions (e.g., laboratory automation), and augmented reality remote support.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Graniten company profile →
OmniAb
HQ: United States
Website
- Description: Provider of antibody discovery technologies for next-generation therapeutics, offering the OmniAb Discovery Platform with diverse antibody repertoires and high-throughput screening via proprietary transgenic animals. Platforms include OmniRat, OmniMouse, and OmniChicken for fully human antibodies, and OmniFlic and OmniClic for bispecific antibodies using a common light chain.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full OmniAb company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Collagen Solutions
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Collagen Solutions
2.2 - Growth funds investing in similar companies to Collagen Solutions
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Collagen Solutions
4.2 - Public trading comparable groups for Collagen Solutions
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →